ZOLL Medical Corporation Announces $50M Share Repurchase Program

Symbols: ZOLL
Posted in: News, Buybacks
Share

ZOLL Medical Corporation (Nasdaq: ZOLL), a manufacturer of resuscitation devices and related software solutions, announced today that its Board of Directors has authorized the repurchase of up to $50 million of the Company's shares of common stock.


 
 
< Previous
Bristol-Myers Squibb and AstraZeneca Announce Meta-Analysis of Clinical Data on Cardiovascular Safety Presented for Investigational Compound Dapagliflozin in Adult Patients with Type 2 Diabetes
Next >
Kohlberg Capital Corporation Receives Notification of Noncompliance From NASDAQ
Share
Printer-friendly version
Send to friend
We're Loving

Benzinga's Premium Memberships

Benzinga's News Delivered Free

Brain Trust